Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 138

Sort by

Sort Order Select

Journal Articles

Olfactomedin 4 Inhibits Erythroid Differentiation of Leukemic Cell Lines Induced By TGF-β: A Model of Preferential Commitment of Del(13q) Hematopoietic Stem Cells in Immune-Mediated Bone Marrow Failure

Kohei Thi Hosokawa, MD PhD, Kohei Hosokawa, MD PhD, Tanabe Mikoto, MD, Md Mohiuddin, Takeshi Yoroidaka, MD, Hiroki Mizumaki, MD, Tatsuya Imi, MD PhD, Masaya Ueno, PhD, Atsushi Hirao, MD PhD, Shinji Nakao, MD PhD

Blood (2019) 134 (Supplement_1): 5000.

https://doi.org/10.1182/blood-2019-127767

Published: 2019

Journal Articles

A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents

Michael A Spinner, Alexey Aleshin, MD MBA, Marianne A Santaguida, PhD, Steven A Schaffert, PhD, Taher Abbasi, MS, MBA, Jeffrey N Sanders, A Scott Patterson, MA, Diane Heiser, PhD, James L Zehnder, Peter L Greenberg, MD

Blood (2019) 134 (Supplement_1): 4239.

https://doi.org/10.1182/blood-2019-129473

Published: 2019

Journal Articles

Expansion of Human Mesenchymal Stromal/Stem Cells Using Standardized Xeno-Free, Serum-Free Culture Condition

Van T. Hoang, PhD, Quynh-Mai Trinh, M.Sc., Phuong TM Dam, PhD, Yen-Nhi Phung, M.Sc., Ngan T.H. Nguyen, Hong-Hue Bui, Minh-Hang Le, M.Sc., Hong-Nhung Trinh, M.Sc., Tuyet-Anh T. Nguyen, M.Sc., Minh Duc Hoang, PhD, Nguyen Thanh Liem, MD, PhD

Blood (2019) 134 (Supplement_1): 3253.

https://doi.org/10.1182/blood-2019-132140

Published: 2019

Journal Articles

Use of Multi-Omics Approach to Produce a Robust Serum-Free Media for the Expansion of T Cells

Sarya G. Mansour, M.A, Pei-Yi Lin, PhD, Anson Pierce, PhD, Curt I Civin, MD

Blood (2019) 134 (Supplement_1): 1053.

https://doi.org/10.1182/blood-2019-124393

Published: 2019

Journal Articles

Cell Adhesion of ALL to Stromal Cells May Mediate CAR T-Cell Resistance: A Novel Escape Mechanism for Immunotherapy

Hye Na Kim, Enzi Jiang, MD PhD, Ruan Yongsheng, MD, Heather Ogana, Nour Abdel-Azim, Justin Le, BS, Annie Luong, Halvard Bonig, MD, Nabil Ahmed, MD, Moghimi Babak, MD, Michael A. Pulsipher, MD, Deepa Bhojwani, MD, Alan S. Wayne, MD, Chintan Parekh, MBBS, Hisham Abdel-Azim, Nora Heisterkamp, Yong-Mi Kim, MD MPH, PhD

Blood (2019) 134 (Supplement_1): 2623.

https://doi.org/10.1182/blood-2019-132131

Published: 2019

Journal Articles

Early Response Observed in Pediatric Patients with Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma Treated with Sequential Chimeric Antigen Receptor T Cells

Wenqun Zhang, MD, Bo Hu, MD, Ling Jing, MD, Jing Yang, MD, Shan Wang, MD, Yang Liu, MD, Juan Du, MD, Yaoliang Ren, MD, Yonghong Zhang, MD

Blood (2019) 134 (Supplement_1): 1945.

https://doi.org/10.1182/blood-2019-125753

Published: 2019

Journal Articles

Leukemia Burden in Peripheral Blood Has Negative Impact on CD19-CART Cell Culture and Its Clinical Efficacy in Patients with Refractory or Relapsed B Cell Acute Lymphoblastic Leukemia

Biping Deng, BS, MD, Jing Pan, Shuangyou Liu, Yuehui Lin, Zhaoli Liu, Yunlong Chen, Xiaoming Qu, Yu 'e Zhang, Zhongxin Zhang, Xuansha Niu, Ming Ma, Tong Wu, MD, Alex Hong Chang, Chunrong Tong

Blood (2019) 134 (Supplement_1): 1957.

https://doi.org/10.1182/blood-2019-126695

Published: 2019

Journal Articles

Wnt5a Induces ROR1-Dependent Upregulation of MMP9 and Enhanced Invasiveness in Chronic Lymphocytic Leukemia

Md Kamrul Hasan, PhD, Laura Z. Rassenti, PhD, George F. Widhopf II, PhD, Thomas J. Kipps, MD PhD

Blood (2019) 134 (Supplement_1): 4274.

https://doi.org/10.1182/blood-2019-131600

Published: 2019

Journal Articles

Ex Vivo Drug Response Profiling Defines Novel Drug Sensitivity Patterns for Predicting Clinical Therapeutic Responses in Myeloid Neoplasms

Alexey Aleshin, MDMBA, Marianne A Santaguida, PhD, Michael A Spinner, MD, Jeffrey N Sanders, A Scott Patterson, Christos Gekas, PhD, Steven Schaffert, PhD, Peter L Greenberg, MD

Blood (2018) 132 (Supplement 1): 4356.

https://doi.org/10.1182/blood-2018-99-120146

Published: 2018

Journal Articles

IDH1 Mutant AML Is Susceptible to Targeting De Novo Lipid Synthesis Independent of 2-Hydroxyglutarate and Has a Distinct Metabolic Profile from IDH2 Mutant AML

Daniel Thomas, MD PhD, Yusuke Nakauchi, MD PhD, Manhong Wu, PhD, Ming Zheng, PhD, Subarna Sinha, PhD, David Dill, PhD, Gary Peltz, MD PhD, Ravindra Majeti, MD PhD

Blood (2018) 132 (Supplement 1): 440.

https://doi.org/10.1182/blood-2018-99-115040

Published: 2018

Journal Articles

Single Cell Resolution of Glucocorticoid Effects on Erythroid Progenitor Cells

Hojun Li, MD PhD, Anirudh Natarajan, PhD, Jideofor Ezike, M Inmaculada Barrasa, PhD, Huan Yang, PhD, Clement Ma, PhD, Styliani Markoulaki, PhD, Harvey Lodish, PhD

Blood (2018) 132 (Supplement 1): 751.

https://doi.org/10.1182/blood-2018-99-112445

Published: 2018

Journal Articles

Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic Leukemia

Rebecca Gardner, MD, Colleen Annesley, MD, Olivia Finney, PhD, Corinne Summers, MD, Adam J. Lamble, MD, Julie Rivers, MD, Kaelin Crews, Lauren Huang, Christopher Brown, Stephanie Mgebroff, Catherine Lindgren, Karen Spratt, PhD, Josh Gustafson, PhD, Adam Johnson, PhD, Julie R. Park, MD, Michael C. Jensen, MD

Blood (2018) 132 (Supplement 1): 278.

https://doi.org/10.1182/blood-2018-99-113126

Published: 2018

Journal Articles

The Effect of the Soluble Guanylyl Cyclase Stimulator Olinciguat on ƴ-Globin Gene Induction in K562 Cells

Joy Miyashiro, Asha Pant, Boris Tchernychev, PhD, Todd G Milne, Mark G Currie, Regina Margaret Graul, Jaime Masferrer

Blood (2018) 132 (Supplement 1): 1078.

https://doi.org/10.1182/blood-2018-99-116011

Published: 2018

Journal Articles

Expression of Recombinant β2GPI and Site-Directed Mutants Provides Insight into the Pathogenesis of Antiphospholipid Syndrome

Ravi Kumar Alluri, PhD, Suman Kundu, MBA, Jack Su, PhD, Sekhar Kambakam, Edward Yu, PhD, Keith R. McCrae, MD

Blood (2018) 132 (Supplement 1): 1226.

https://doi.org/10.1182/blood-2018-99-117665

Published: 2018

Journal Articles

Endothelial Colony Forming Cells from Individuals with Low VWF Levels Demonstrate Impairment in Stimulated VWF Release

Christopher J. Ng, MD, Katrina J. Ashworth, MS, Marilyn J Manco-Johnson, MD, Christopher Baker, MD, Jorge Di Paola, MD

Blood (2017) 130 (Supplement 1): 21.

https://doi.org/10.1182/blood.V130.Suppl_1.21.21

Published: 2017

Journal Articles

Wnt5a Induces Interleukin-6 Via a ROR1-Dependent Pathway in Chronic Lymphocytic Leukemia, Leading to Leukemia-Cell Activation of STAT3

Yun Chen, PhD, Liguang Chen, PhD, Jian Yu, PhD, Ling Zhang, Laura Z. Rassenti, PhD, Thomas J. Kipps, MD

Blood (2017) 130 (Supplement 1): 4282.

https://doi.org/10.1182/blood.V130.Suppl_1.4282.4282

Published: 2017

Journal Articles

The Exhaustion of Adult Hematopoietic Stem Cells in Ex Vivo Cultures Can Be Overcome by a Histone Deacetylase Inhibitor

Eran Zimran, MD, Luena Papa, PhD, Mansour Djedaini, BS, Ronald Hoffman, MD

Blood (2017) 130 (Supplement 1): 655.

https://doi.org/10.1182/blood.V130.Suppl_1.655.655

Published: 2017

Journal Articles

Primary Chronic Lymphocytic Leukemia Cells Can be Maintained Long-Term in Serum-Free, Cytokine-Free 3D Culture

Joana Dos Santos, MSc, Louise Enfield, Susana Brito Dos Santos, MSc, Mark C Allenby, MSc, Sophie Zemenides, MD, Athanasios Mantalaris, PhD, Nicki Panoskaltsis, MD PhD FRCP

Blood (2017) 130 (Supplement 1): 2989.

https://doi.org/10.1182/blood.V130.Suppl_1.2989.2989

Published: 2017

Journal Articles

Customized Induced Pluripotent Stem Cell-Derived Red Cell Reagents

David Posocco, Hyun H An, Jean Ann Maguire, Judith Aeschlimann, Deborah L French, PhD, Paul Gadue, PhD, Connie M. Westhoff, PhD, Stella T Chou, MD

Blood (2017) 130 (Supplement 1): 3.

https://doi.org/10.1182/blood.V130.Suppl_1.3.3

Published: 2017

Journal Articles

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

Angélique Bruyer, MSc, Nicolas Robert, Stéphanie Boireau, Christophe Hirtz, Laurent Tiers, Laure Vincent, Guillaume Cartron, Dirk Hose, MD, Anja Seckinger, Bernard Klein, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 3045.

https://doi.org/10.1182/blood.V130.Suppl_1.3045.3045

Published: 2017

NARROW

Olfactomedin 4 Inhibits Erythroid Differentiation of Leukemic Cell Lines Induced By TGF-β: A Model of Preferential Commitment of Del(13q) Hematopoietic Stem Cells in Immune-Mediated Bone Marrow Failure

A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents

Expansion of Human Mesenchymal Stromal/Stem Cells Using Standardized Xeno-Free, Serum-Free Culture Condition

Use of Multi-Omics Approach to Produce a Robust Serum-Free Media for the Expansion of T Cells

Cell Adhesion of ALL to Stromal Cells May Mediate CAR T-Cell Resistance: A Novel Escape Mechanism for Immunotherapy

Early Response Observed in Pediatric Patients with Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma Treated with Sequential Chimeric Antigen Receptor T Cells

Leukemia Burden in Peripheral Blood Has Negative Impact on CD19-CART Cell Culture and Its Clinical Efficacy in Patients with Refractory or Relapsed B Cell Acute Lymphoblastic Leukemia

Wnt5a Induces ROR1-Dependent Upregulation of MMP9 and Enhanced Invasiveness in Chronic Lymphocytic Leukemia

Ex Vivo Drug Response Profiling Defines Novel Drug Sensitivity Patterns for Predicting Clinical Therapeutic Responses in Myeloid Neoplasms

IDH1 Mutant AML Is Susceptible to Targeting De Novo Lipid Synthesis Independent of 2-Hydroxyglutarate and Has a Distinct Metabolic Profile from IDH2 Mutant AML

Single Cell Resolution of Glucocorticoid Effects on Erythroid Progenitor Cells

Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic Leukemia

The Effect of the Soluble Guanylyl Cyclase Stimulator Olinciguat on ƴ-Globin Gene Induction in K562 Cells

Expression of Recombinant β2GPI and Site-Directed Mutants Provides Insight into the Pathogenesis of Antiphospholipid Syndrome

Endothelial Colony Forming Cells from Individuals with Low VWF Levels Demonstrate Impairment in Stimulated VWF Release

Wnt5a Induces Interleukin-6 Via a ROR1-Dependent Pathway in Chronic Lymphocytic Leukemia, Leading to Leukemia-Cell Activation of STAT3

The Exhaustion of Adult Hematopoietic Stem Cells in Ex Vivo Cultures Can Be Overcome by a Histone Deacetylase Inhibitor

Primary Chronic Lymphocytic Leukemia Cells Can be Maintained Long-Term in Serum-Free, Cytokine-Free 3D Culture

Customized Induced Pluripotent Stem Cell-Derived Red Cell Reagents

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only